IUX24
TopMarketWorldEconomyFinanceTechnologyBusinessPoliticsAnalysis & Opinion

Bayer files lawsuit against Johnson and Johnson over prostate cancer drug

German drugmaker Bayer filed a lawsuit today in a New York court against Johnson and Johnson. The legal action involves the prostate cancer drug Nubeqa.

Insights:
Bayer filed a lawsuit in a New York court on Feb. 23, 2026, against Johnson & Johnson and its unit Janssen Biotech Inc. This legal action concerns Bayer's Nubeqa prostate cancer drug and establishes a formal legal dispute between the major pharmaceutical firms. The development is immediately material to company stakeholders and the legal and market context within the United States USUS.
The 120-meter-high Bayer Cross, the logo of German pharmaceutical and chemical company Bayer AG made of 1,710 LED glass bulbs, is pictured outside the Chempark industrial park in Leverkusen, Germany, on September 23, 2023. REUTERS/Wolfgang Rattay
The 120-meter-high Bayer Cross, the logo of German pharmaceutical and chemical company Bayer AG made of 1,710 LED glass bulbs, is pictured outside the Chempark industrial park in Leverkusen, Germany, on September 23, 2023. REUTERS/Wolfgang Rattay
IUX24

IUX24 AI-powered financial news and market intelligence. Think and act like smart money.

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. All rights reserved.

Powered by AI • Made with precision

IUX24 is an information and analytics platform providing news, market data, analytical tools, and AI-powered features for informational and educational purposes. The Services and information provided do not constitute investment advice, trading signals, or brokerage services. Investing involves risk, and Users should carefully evaluate information before making investment decisions.